Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Latest press releases
- GSK and Vir Biotechnology announce the start of the EMA rolling review of VIR-7831 (sotrovimab) for the early treatment of COVID-19
- ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV
- GSK students take on the role of engineers during GSK Science in the Summer™ in partnership with The Franklin Institute
- GSK delivers Q1 sales of £7.4 billion -18% AER, -15% CER Total EPS 21.5p, -32% AER, -25% CER; Adjusted EPS 22.9p -39% AER, -33% CER
GSK US Twitter
-
GSKUS @GSKUS
#DYK some people don’t recognize when they’re experiencing uncontrolled #asthma symptoms? If persistent asthma attacks continue despite treatment, there may be more to the story. Learn more about the condition this #AsthmaAwarenessMonth.
about 14 hours ago -
GSKUS @GSKUS
#DYK the 8th of May is #WorldOvarianCancerDay? Learn more about the signs & symptoms of #OvarianCancer 👇 and learn about the disease here: gsk.to/3b21zZOHD#WOCD20212#PowerfulTogethereoM
about 17 hours ago
-
GSK in the US
The US is home to ~15,000 GSK employees across 50 states, 9 manufacturing facilities and multiple R&D centers.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
